EPCORITAMAB for Diffuse large b-cell lymphoma stage i: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 59 adverse event reports in the FDA FAERS database where EPCORITAMAB was used for Diffuse large b-cell lymphoma stage i.

Most Reported Side Effects for EPCORITAMAB

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	551	27.0%	66	507
Pyrexia	258	12.6%	51	234
Off label use	229	11.2%	69	182
Febrile neutropenia	219	10.7%	19	216
Pneumonia	154	7.6%	38	138
Covid-19	125	6.1%	25	108
Sepsis	106	5.2%	46	95
Hypotension	95	4.7%	31	86
Diffuse large b-cell lymphoma	86	4.2%	46	15
Neutropenia	84	4.1%	24	66
Diarrhoea	83	4.1%	9	78
Disease progression	79	3.9%	42	36
Immune effector cell-associated neurotoxicity syndrome	78	3.8%	34	47
C-reactive protein increased	75	3.7%	2	74
Thrombocytopenia	68	3.3%	24	57